US 10202602
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
granted A61KA61K31/496A61K31/5377
Quick answer
US patent 10202602 (Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups) held by Sarepta Therapeutics, Inc. expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/496, A61K31/5377, A61P, A61P13/12